GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List

Explanation to Bollinger's Bands

Bollinger Bands was created by John Bollinger in the early 1980s, its purpose is to define price action relative to the assets highs and lows. This technical indicator is used to identify buy and sell signals and has proven very well in doing so.

Bollinger Bands consist of a set of three curves drawn in relation to securities prices. The middle band is a measure of the intermediate-term trend, usually a simple moving average, that serves as the base for the upper and lower bands. The interval between the upper and lower bands and the middle band is determined by volatility, typically the standard deviation of the same data that were used for the average. StockInvest.us uses Bollingers suggested 20 day average.

Middle Bollinger Band = 20-period simple moving average
Upper Bollinger Band = Middle Bollinger Band + 2 * 20-period standard deviation
Lower Bollinger Band = Middle Bollinger Band - 2 * 20-period standard deviation

BandWidth defines the current width of the band.
%b defines the current position within the band.

BandWidth = (Upper Bollinger Band - Lower Bollinger Band) / Middle Bollinger Band
%b = (Last - Lower Bollinger Band) / (Upper Bollinger Band - Lower Bollinger Band)

Live Samples:

Bollinger Bottleneck Buy Pattern 1
Bollinger Bottleneck Buy Pattern 2
Bollinger Bottleneck Sell Pattern

Bottlenecks in bandwidth indicate an upcoming change. Break up through the moving average line or continuous movements above the moving average line indicate a break up, and vice versa.

Source: http://www.bollingerbands.com

RSI low/high Values: [ 20 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of EVAX
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Evaxion Biotech A/S stock price ended at $4.31 on Friday, after gaining 2.13%.
(Updated on Apr 19, 2024)

Buy or Hold candidate since Apr 02, 2024 Gain 11.08% PDF

The Evaxion Biotech A/S stock price gained 2.13% on the last trading day (Friday, 19th Apr 2024), rising from $4.22 to $4.31. It has now gained 3 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. During the last trading day the stock fluctuated 5.24% from a day low at $4.19 to a day high of $4.41. The price has risen in 6 of the last 10 days and is up by 16.8% over the past 2 weeks. Volume fell on the last day by -4 thousand shares and in total, 31 thousand shares were bought and sold for approximately $133.36 thousand. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -20.62% during the next 3 months and, with a 90% probability hold a price between $1.15 and $6.76 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

EVAX Signals & Forecast

The Evaxion Biotech A/S stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $4.11 and $3.43. A breakdown below any of these levels will issue sell signals. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Wednesday, January 24, 2024, and so far it has fallen -59.53%. Further fall is indicated until a new bottom pivot has been found. Volume fell during the last trading day while the price increased. This causes a divergence and may be considered as an early warning, but it may also not.

Support, Risk & Stop-loss for Evaxion Biotech A/S stock

On the downside, the stock finds support just below today's level from accumulated volume at $3.99 and $3.93. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Evaxion Biotech A/S finds support just below today's level at $3.99. If this is broken, then the next support from accumulated volume will be at $3.93 and $3.88.

This stock may move very much during the day (volatility) and with periodic low trading volume this stock is considered to be "very high risk". During the last day, the stock moved $0.219 between high and low, or 5.24%. For the last week the stock has had daily average volatility of 5.25%.

Our recommended stop-loss: $4.09 (-5.02%) (This stock has very high daily movements and this gives very high risk. There is a sell signal from a pivot top found 60 days ago.)

Trading Expectations (EVAX) For The Upcoming Trading Day Of Monday 22nd

For the upcoming trading day on Monday, 22nd we expect Evaxion Biotech A/S to open at $4.30, and during the day (based on 14 day Average True Range), to move between $3.99 and $4.63, which gives a possible trading interval of +/-$0.322 (+/-7.48%) up or down from last closing price. If Evaxion Biotech A/S takes out the full calculated possible swing range there will be an estimated 14.95% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $4.38 (1.62%) than the support at $3.99 (7.42%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Evaxion Biotech A/S stock A Buy?

Several short-term signals are positive, despite the stock being in a falling trend, we conclude that the current level may hold a buying opportunity as there is a fair chance for stock to perform well in the short-term.

Current score: 2.694 Buy Candidate Unchanged

Predicted Opening Price for Evaxion Biotech A/S of Monday, April 22, 2024

Fair opening price April 22, 2024 Current price
$4.30 ( 0.158%) $4.31

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for EVAX

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 4.52 4.93 %
R2 4.44 2.99 %
R1 4.39 1.79 %
Current price: 4.31
Support S1 4.22 -2.10 %
S2 4.17 -3.30 %
S3 4.08 -5.25 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 4.99 15.78 %
R2 4.60 6.73 %
R1 4.38 1.62 %
Current price 4.31
Support S1 3.99 -7.42%
S2 3.93 -8.82%
S3 3.88 -9.98%

FAQ

What is the symbol for Evaxion Biotech A/S Stock and on which exchange is it traded?
The symbol for Evaxion Biotech A/S is EVAX and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Evaxion Biotech A/S Stock?
Several short-term signals are positive, despite the stock being in a falling trend, we conclude that the current level may hold a buying opportunity as there is a fair chance for stock to perform well in the short-term.

How to buy Evaxion Biotech A/S Stock?
Evaxion Biotech A/S Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Evaxion Biotech A/S Stock.

What's the current price of Evaxion Biotech A/S Stock?
As of the end of day on the 2024-04-19, the price of an Evaxion Biotech A/S (EVAX) share was $4.31.

What is the 52-week high and low for Evaxion Biotech A/S Stock?
The 52-week high for Evaxion Biotech A/S Stock is $13.55 and the 52-week low is $0.470.

What is the market capitalization of Evaxion Biotech A/S Stock?
As of the 2024-04-19, the market capitalization of Evaxion Biotech A/S is 22.477M.

When is the next earnings date for Evaxion Biotech A/S?
The upcoming earnings date for Evaxion Biotech A/S is May 29, 2024.
Click to get the best stock tips daily for free!

About Evaxion Biotech A/S

Evaxion Biotech A/S Evaxion Biotech A/S, a clinical-stage biotech company, engages in developing artificial intelligence-powered immunotherapies for cancers, bacterial diseases, and viral infections. The company develops EVX-01, a cancer immunotherapy that is in clinical Phase IIb trial for metastatic melanoma; EVX-02, a DNA-based cancer immunotherapy that is in Phase IIa trial for adjuvant melanoma; and EVX-03, a DNA-based immunotherapy for the treatment of various... EVAX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT